West Pharmaceutical Services

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments.

CEO

Eric Mark Green

CEOEric Mark Green

Employees

10,600

Employees10,600

Headquarters

Exton, Pennsylvania

HeadquartersExton, Pennsylvania

Founded

1923

Founded1923

Employees

10,600

Employees10,600

WST Key Statistics

Market cap

16.63B

Market cap16.63B

Price-Earnings ratio

34.46

Price-Earnings ratio34.46

Dividend yield

0.37%

Dividend yield0.37%

Average volume

1.33M

Average volume1.33M

High today

$232.05

High today$232.05

Low today

$223.83

Low today$223.83

Open price

$229.63

Open price$229.63

Volume

1.54M

Volume1.54M

52 Week high

$347.14

52 Week high$347.14

52 Week low

$187.43

52 Week low$187.43

Stock Snapshot

With a market cap of 16.63B, West Pharmaceutical Services(WST) trades at $231.11. The stock has a price-to-earnings ratio of 34.46 and currently yields dividends of 36.5%.

On 2026-01-31, West Pharmaceutical Services(WST) stock traded between a low of $223.83 and a high of $232.05. Shares are currently priced at $231.11, which is +3.3% above the low and -0.4% below the high.

West Pharmaceutical Services(WST) shares are trading with a volume of 1.54M, against a daily average of 1.33M.

During the past year, West Pharmaceutical Services(WST) stock moved between $187.43 at its lowest and $347.14 at its peak.

WST News

Simply Wall St 1d

Is West Pharmaceutical Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat?

West Pharmaceutical Services recently announced a definitive agreement to sell all manufacturing and supply rights for its SmartDose® 3.5mL On-Body Delivery Sys...

TipRanks 4d

West Pharmaceutical Services: GLP-1 Dependency, Emerging Oral-Formulation Risks, and Insufficient Diversification Justify Hold Rating

Morgan Stanley analyst Kallum Titchmarsh has maintained their neutral stance on WST stock, giving a Hold rating yesterday. Claim 50% Off TipRanks Premium Unlock...

Nasdaq 5d

Ex-Dividend Reminder: West Pharmaceutical Services, Heritage Financial and Entegris

Looking at the universe of stocks we cover at Dividend Channel, on 1/28/26, West Pharmaceutical Services, Inc. (Symbol: WST), Heritage Financial Corp (Symbol: H...

Analyst ratings

80%

of 20 ratings

Buy

80%

Hold

20%

Sell

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.